Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 237

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 237
---
 the table below have sole voting and investment power with respect to all Ordinary Shares
shown as beneficially owned by them. The percentage of beneficial ownership is based upon 6,685,918,922 Ordinary Shares outstanding as
of December 31, 2024. Ordinary Shares subject to options or warrants currently exercisable or exercisable within 60 days of December 31,
2024 are deemed to be outstanding and beneficially owned by the person holding the options for the purposes of computing the percentage
of beneficial ownership of that person and any group of which that person is a member, but are not deemed outstanding for the purpose
of computing the percentage of beneficial ownership for any other person. Unless otherwise indicated, the address for each holder listed
below is Biodexa Pharmaceuticals PLC, Caspian Point, 1 Caspian Way, Cardiff, CF10 4DQ, United Kingdom. All holders of Ordinary Shares,
including those shareholders listed below, have the same voting rights with respect to such shares.

| Name of Beneficial Owner                                   |     | Amount and Nature 
 Of Ownership      |             |     | Percent      
 of Class (%) |      |
| Major Shareholders                                         |     |                   |             |     |              |      |
| Entities Affiliated with Bigger Funds (1)**                |     |                   | 742,054,550 |     |              | 9.99 |
| Brio Capital Master Fund Ltd. (2)**                        |     |                   | 742,054,550 |     |              | 9.99 |
| Entities Affiliated with Cavalry Funds (3)**               |     |                   | 742,054,550 |     |              | 9.99 |
| Directors and Senior Management:                           |     |                   |             |     |              |      |
| Ann Merchant (4)                                           |     |                   |   7,200,000 |     |              |    * |
| Stephen Parker (5)                                         |     |                   |  14,400,000 |     |              |    * |
| Stephen Stamp (6)                                          |     |                   |  21,518,875 |     |              |    * |
| Simon Turton, Ph.D. (7)                                    |     |                   |   7,202,765 |     |              |    * |
| Sijmen de Vries, M.D. (8)                                  |     |                   |   7,200,